 interv report phase i-ii studi multipl modal treatment invas bladder cancer bladder-spar trial clinician massachusett gener hospit cycl methotrex cisplatin vinblastin mcv radiotherapi cisplatin patient muscle-invas bladder cancer eleven patient protocol overal toxic formid total patient aliv patient seri full treatment protocol surviv rate month interim analysi treatment limit success live bladder